108 related articles for article (PubMed ID: 17431391)
1. The relation of serum anti-(GalNAc beta) and -para-Forssman disaccharide IgG levels to the progression and histological grading of gastrointestinal cancer.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Chuzmarov VI; Afanasyev VP
Exp Oncol; 2007 Mar; 29(1):61-6. PubMed ID: 17431391
[TBL] [Abstract][Full Text] [Related]
2. IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival.
Kurtenkov O; Klaamas K; Rittenhouse-Olson K; Vahter L; Sergejev B; Miljukhina L; Shljapnikova L
Exp Oncol; 2005 Jun; 27(2):136-40. PubMed ID: 15995632
[TBL] [Abstract][Full Text] [Related]
3. The level of anti-(GalNAc beta) and anti-para-Forssman disaccharide IgG antibodies in patients with gastrointestinal cancer: relation to survival.
Smorodin EP; Kurtenkov OA; Sergeyev BL
Exp Oncol; 2013 Jun; 35(2):89-92. PubMed ID: 23828381
[TBL] [Abstract][Full Text] [Related]
4. The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients.
Kodar K; Kurtenkov O; Klaamas K
Immunol Invest; 2009; 38(8):704-17. PubMed ID: 19860583
[TBL] [Abstract][Full Text] [Related]
5. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
[TBL] [Abstract][Full Text] [Related]
6. The significance of anti-sialyl-Tn antibodies in patients with colorectal and breast cancer.
Coomber DW; Hawkins NJ; Dalley D; Ward RL
Neoplasma; 1998; 45(1):12-6. PubMed ID: 9604995
[TBL] [Abstract][Full Text] [Related]
7. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer.
Albanopoulos K; Armakolas A; Konstadoulakis MM; Leandros E; Tsiompanou E; Katsaragakis S; Alexiou D; Androulakis G
Am J Gastroenterol; 2000 Apr; 95(4):1056-61. PubMed ID: 10763959
[TBL] [Abstract][Full Text] [Related]
9. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
11. The characterization of IgG antibodies to GalNAc beta-terminated glycans of gastric cancer survivors.
Smorodin EP; Sergeyev BL; Kurtenkov OA
Exp Oncol; 2014 Mar; 36(1):38-43. PubMed ID: 24691283
[TBL] [Abstract][Full Text] [Related]
12. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
13. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-12 levels in patients with gastric cancer.
Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
[TBL] [Abstract][Full Text] [Related]
15. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
16. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies detecting different epitopes on the Forssman glycolipid hapten.
Sonnenberg A; van Balen P; Hengeveld T; Kolvenbag GJ; Van Hoeven RP; Hilgers J
J Immunol; 1986 Aug; 137(4):1264-9. PubMed ID: 2426359
[TBL] [Abstract][Full Text] [Related]
18. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].
Yang G; Hu F; Jia J
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940
[TBL] [Abstract][Full Text] [Related]
19. Specificity of serum anti-A(di) IgG antibodies from patients with gastrointestinal cancer.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Branovets JS; Izotova JG; Formanovsky AA
J Immunoassay Immunochem; 2011; 32(3):170-90. PubMed ID: 21574090
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]